Dr. Reddy's and Nestle India to form JV for health science nutraceutical portfolio
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
Versavo is the first Dr. Reddy's biosimilar product to be approved and launched in the UK
The acquisition is done through cash consideration, by way of conversion of SAFE (Simple Agreement for Future Equity) investment of US$ 2 Million to Preferred A-1 Shares
Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis
Dr. Reddy's Laboratories has been issued a Form 483 with three observations
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Subscribe To Our Newsletter & Stay Updated